| Name | Methyl 2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carboxylate |
|---|---|
| Synonyms |
2-amino-5-(3-fluoro-phenyl)thiazole-4-carboxylic acid methyl ester
methyl 2-amino-5-(3-fluorophenyl)-4-thiazolecarboxylate |
| Molecular Formula | C11H9FN2O2S |
|---|---|
| Molecular Weight | 252.26500 |
| Exact Mass | 252.03700 |
| PSA | 94.18000 |
| LogP | 2.24810 |
| HS Code | 2934100090 |
|---|
|
~%
127918-93-8 |
| Literature: Actelion Pharmaceuticals Ltd. Patent: US2012/115916 A1, 2012 ; Location in patent: Page/Page column 23-24; 35 ; |
|
~%
127918-93-8 |
| Literature: Actelion Pharmaceuticals Ltd. Patent: US2012/115916 A1, 2012 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |